Newsroom

Sauad Farmacêutica, a subsidiary of UAE based pharmaceutical manufacturer Neopharma, will be participating the CPhI Middle East and Africa in Abu Dhabi, United Arab Emirates from 16 – 18 September 2019. The Brazil subsidiary of UAE based global manufacturer, Neopharma showcase products and manufacturing facilities at Stand M40

To know more about Sauad Farmacêutica, our global operations therapeutic segments please meet the team at CPhI show or alternatively contact us at info@sauadfarmaceutica.com.br

About CPhI
CPhI is a well- established pharmaceutical event known for bringing together the suppliers, distributors and buyers from the pharmaceutical industry. The event hosts exhibitions, conferences, free seminars, awards and pharma community charity expedition across 9 locations worldwide.

About Sauad Farmaceutica
Sauad Indústria Farmacêutica is a subsidiary of UAE based, global pharmaceutical manufacturer, Neopharma. A dynamic global organization dedicated to fulfilling patients' needs by providing quality medicines and innovative medications at affordable cost. With an Integrated Health Care approach, Sauad Farmacêutica is dedicated to deliver breakthrough solutions to the market, solve complex challenges, and most importantly, meet partners and patients' expectations through high quality, innovative and accessible solutions. To know more visit us at www.sauadfarmaceutica.com.br

About Neopharma
Neopharma, is one of the largest pharmaceutical companies in the MENA region with 100% subsidiaries in USA, Japan, Brazil, and India. A vertically integrated business, comprising of API, R&D and Formulation facilities in emerging and regulated markets. This enable us to deliver quality innovative and generic products in a timely manner at affordable prices in over 50 countries worldwide. Neopharma's global presence is supported by 7 manufacturing facilities spread across 4 continents delivering a wide range of branded and generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered are acute and chronic therapies. For further information, visit us atwww.neopharma.com


Sauad Farmacêutica, a subsidiary of UAE based pharmaceutical manufacturer Neopharma, received import lisence from Brazil’s health regulatory agency, AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (ANVISA). The lisence was granted through Resolution-RE Nº 869 for the importation, storage, distribution and marketing of cosmetic products.

About Sauad Farmaceutica

Sauad Indústria Farmacêutica is a subsidiary of UAE based, global pharmaceutical manufacturer, Neopharma. A dynamic global organization dedicated to fulfilling patients' needs by providing quality medicines and innovative medications at affordable cost. With an Integrated Health Care approach, Sauad Farmacêutica is dedicated to deliver breakthrough solutions to the market, solve complex challenges, and most importantly, meet partners and patients' expectations through high quality, innovative and accessible solutions. To know more visit us at www.sauadfarmaceutica.com.br

About Neopharma

Neopharma, is one of the largest pharmaceutical companies in the MENA region with 100% subsidiaries in USA, Japan, Brazil, and India. A vertically integrated business, comprising of API, R&D and Formulation facilities in emerging and regulated markets. This enable us to deliver quality innovative and generic products in a timely manner at affordable prices in over 50 countries worldwide. Neopharma's global presence is supported by 7 manufacturing facilities spread across 4 continents delivering a wide range of branded and generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered are acute and chronic therapies. For further information, visit us at www.neopharma.com

TOP